A 54-year-old male with advanced decompensated cirrhosis presents with severe ascites, pronounced jaundice, asterixis, and confusion. His laboratory results show elevated bilirubin, prolonged INR, low albumin, and elevated creatinine levels. Which of the following interventions should the nurse prioritize to address the patient's current state of hemodynamic instability and prevent further deterioration?

C) Administer intravenous albumin and terlipressin to address suspected hepatorenal syndrome.

A) Administer intravenous furosemide to reduce fluid overload.

B) Initiate lactulose therapy to decrease serum ammonia levels.

C) Administer intravenous albumin and terlipressin to address suspected hepatorenal syndrome.

D) Prepare the patient for paracentesis to relieve ascites and improve respiratory function.

A 54-year-old male patient with advanced decompensated cirrhosis, severe ascites, significant jaundice, and hepatic encephalopathy is being evaluated. Laboratory results show elevated bilirubin, AST, and ALT levels, prolonged INR, low albumin, and elevated creatinine. The patient presents with hypotension and tachycardia. Which of the following nursing interventions should be prioritized to stabilize the patient and prevent further deterioration?

C) Administer lactulose to reduce ammonia levels and manage hepatic encephalopathy.

A) Administer diuretics to manage fluid overload and reduce ascites.

B) Initiate intravenous albumin infusion to address coagulopathy and improve hemodynamic stability.

C) Administer lactulose to reduce ammonia levels and manage hepatic encephalopathy.

D) Start terlipressin therapy to improve renal function and address suspected hepatorenal syndrome.

A patient with suspected hepatorenal syndrome receiving intravenous albumin and terlipressin therapy shows worsening renal function and a decrease in urine output. Concurrently, the patient on lactulose therapy for hepatic encephalopathy presents with metabolic alkalosis and hypokalemia. As the nurse evaluates the patient's condition, which nursing intervention is the most appropriate to prioritize at this time?

D) Collaborate with the healthcare provider to adjust lactulose dosage and introduce rifaximin therapy.

A) Increase the dose of lactulose to enhance the reduction of ammonia levels.

B) Administer potassium supplements to address the hypokalemia while continuing current lactulose dosage.

C) Initiate renal replacement therapy immediately to address the acute renal failure.

D) Collaborate with the healthcare provider to adjust lactulose dosage and introduce rifaximin therapy.

A patient with suspected hepatorenal syndrome is experiencing worsening renal function despite treatment with intravenous albumin and terlipressin. Additionally, the patient on lactulose therapy is now showing signs of metabolic alkalosis and hypokalemia. Which of the following nursing interventions is the most appropriate to address the current clinical scenario?

C) Adjust the lactulose dosage and initiate rifaximin therapy to manage hepatic encephalopathy while monitoring electrolyte levels.

A) Increase the dose of lactulose to enhance its effectiveness in managing hepatic encephalopathy.

B) Initiate high-dose potassium supplementation to rapidly correct hypokalemia.

C) Adjust the lactulose dosage and initiate rifaximin therapy to manage hepatic encephalopathy while monitoring electrolyte levels.

D) Discontinue lactulose therapy immediately to prevent further electrolyte disturbances.

A patient with advanced liver failure and new onset gastrointestinal bleeding presents with hypotension, tachycardia, and signs of hepatic encephalopathy. Given these findings, what should be the nurse's first priority in managing this patient's care?

B) Initiate a blood transfusion to address the dropping hemoglobin levels.

A) Administer intravenous vasopressors to stabilize blood pressure.

B) Initiate a blood transfusion to address the dropping hemoglobin levels.

C) Prepare the patient for an urgent endoscopy to identify the source of bleeding.

D) Administer lactulose to reduce serum ammonia levels and treat hepatic encephalopathy.

A patient with advanced liver failure presents with ascites, elevated serum ammonia, hypotension, tachycardia, and signs of gastrointestinal bleeding. The healthcare team is prioritizing interventions. Which of the following actions should the nurse anticipate as the highest priority to address the patient's current condition?

C) Administer intravenous fluids and consider vasopressor support to stabilize hemodynamics.

A) Administer lactulose to reduce serum ammonia levels.

B) Prepare for an urgent endoscopic evaluation to identify the source of bleeding.

C) Administer intravenous fluids and consider vasopressor support to stabilize hemodynamics.

D) Transfuse packed red blood cells to manage the drop in hemoglobin.

A patient with progressive hepatic encephalopathy and worsening ascites is experiencing hemodynamic instability and has developed acute kidney injury (AKI). The patient's clinical presentation includes decreased Glasgow Coma Scale score, pleural effusion, and significant gastrointestinal bleeding. As the nurse assessing the situation, what is the most appropriate immediate action to support the patient's respiratory status while addressing the risk of further renal compromise?

B) Initiate non-invasive ventilation to support respiratory function and reduce workload.

A) Increase the supplemental oxygen flow rate to improve oxygen saturation.

B) Initiate non-invasive ventilation to support respiratory function and reduce workload.

C) Elevate the head of the bed to 45 degrees and reassess the patient's breathing pattern.

D) Administer diuretics to reduce fluid overload and improve lung function.

A patient with worsening hepatic encephalopathy, pleural effusion, and gastrointestinal bleeding develops acute kidney injury. The healthcare team is managing the patient's complex condition, which includes hemodynamic instability and coagulopathy. As a nurse, what is the most critical action to prioritize in this scenario?

C) Adjust the vasopressor dose to maintain adequate mean arterial pressure.

A) Increase the rate of intravenous fluid administration to improve urine output.

B) Initiate renal replacement therapy to address the acute kidney injury.

C) Adjust the vasopressor dose to maintain adequate mean arterial pressure.

D) Prepare the patient for an urgent endoscopic procedure to control the bleeding.

A patient with advanced liver disease is experiencing portal vein thrombosis, increased ascitic fluid, and hepatic encephalopathy. Which of the following nursing interventions is the most critical to prioritize in managing this patient's current condition?

C) Prepare for paracentesis to relieve ascitic fluid pressure on the diaphragm.

A) Administer lactulose to reduce ammonia levels and manage hepatic encephalopathy.

B) Initiate anticoagulation therapy to address portal vein thrombosis.

C) Prepare for paracentesis to relieve ascitic fluid pressure on the diaphragm.

D) Increase norepinephrine dosage to stabilize blood pressure.

A patient with advanced liver disease presents with rapidly increasing ascitic fluid, portal vein thrombosis, and worsening liver function tests. Despite norepinephrine support, the patient's blood pressure remains critically low. What is the priority nursing intervention to address the patient's current hemodynamic instability and respiratory compromise?

C) Prepare for paracentesis to relieve ascitic pressure and improve respiratory function

A) Administer diuretics to reduce ascitic fluid and relieve diaphragmatic pressure

B) Initiate anticoagulation therapy to manage portal vein thrombosis and improve hepatic circulation

C) Prepare for paracentesis to relieve ascitic pressure and improve respiratory function

D) Increase norepinephrine dosage to maintain adequate blood pressure and prevent further deterioration

Hep b - Nursing Case Study

Pathophysiology

• Primary mechanism: Hepatitis B virus (HBV) invades hepatocytes, integrating its DNA into the host genome, which triggers an immune-mediated cytotoxic T-cell response against infected liver cells, leading to hepatocyte destruction and liver inflammation.

• Secondary mechanism: Chronic HBV infection can result in persistent immune activation and oxidative stress, promoting fibrogenesis. Over time, this leads to the accumulation of extracellular matrix proteins and progression to liver fibrosis and cirrhosis.

• Key complication: Cirrhosis significantly alters hepatic architecture and function, heightening the risk of hepatocellular carcinoma due to ongoing inflammation, cell turnover, and genetic mutations within regenerating hepatocytes.

Patient Profile

Demographics:

54-year-old male, construction worker

History:

• Key past medical history: Chronic Hepatitis B infection diagnosed 10 years ago, cirrhosis, Type 2 diabetes, hypertension

• Current medications: Tenofovir, Metformin, Lisinopril, Propranolol

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Severe abdominal pain and jaundice

• Key symptoms: Ascites, confusion, weakness, and fatigue

• Vital signs: Blood pressure 88/54 mmHg, heart rate 112 bpm, respiratory rate 24 breaths per minute, temperature 38.4°C (101.1°F), SpO2 89% on room air

Section 1

As the healthcare team continues the initial assessment of the 54-year-old male patient, further examination reveals significant findings that necessitate immediate attention and advanced clinical reasoning. The abdominal examination indicates severe ascites, with a fluid wave present and marked abdominal distension, suggesting advanced decompensated cirrhosis. The patient's jaundice is pronounced, with scleral icterus and deep yellow discoloration of the skin, indicating worsening liver dysfunction. Neurological assessment reveals marked confusion and asterixis, signs indicative of hepatic encephalopathy, potentially exacerbated by the accumulation of ammonia and other toxins due to liver failure.

Laboratory results further complicate the clinical picture. Liver function tests show markedly elevated bilirubin levels at 15 mg/dL, with AST and ALT elevated at 200 U/L and 180 U/L, respectively. The patient's INR is significantly prolonged at 2.5, reflecting coagulopathy, while albumin levels are critically low at 2.1 g/dL, contributing to the ascites and edema. Additionally, renal function tests reveal an elevated creatinine level of 2.3 mg/dL, raising concerns for hepatorenal syndrome, a serious complication of advanced liver disease. These findings, coupled with the patient's hypotension and tachycardia, suggest a state of significant hemodynamic instability, necessitating urgent intervention to stabilize the patient and prevent further deterioration.

Faced with these complex challenges, the healthcare team must employ advanced clinical judgment to prioritize interventions. The immediate goals include addressing the patient's hemodynamic instability, managing ascites and hepatic encephalopathy, and preventing progression of renal impairment. This involves careful fluid management to avoid exacerbating ascites, administration of lactulose to reduce ammonia levels, and potential initiation of terlipressin or albumin therapy to address the suspected hepatorenal syndrome. Continuous monitoring and reassessment will be critical as the team navigates this multifaceted clinical scenario, setting the stage for further developments in the patient's condition.

Section 2

As the healthcare team implements the initial interventions, close monitoring reveals a change in the patient's status, necessitating further critical decision-making. Despite the administration of intravenous albumin and the initiation of terlipressin therapy to address the suspected hepatorenal syndrome, the patient's renal function continues to deteriorate. Follow-up laboratory tests reveal a further increase in creatinine to 3.1 mg/dL, and a rapid rise in blood urea nitrogen (BUN) to 68 mg/dL, indicating worsening renal impairment. This decline is accompanied by a decrease in urine output, categorized as oliguria, which confirms the progression towards acute renal failure secondary to hepatorenal syndrome.

Simultaneously, the patient exhibits a paradoxical response to the lactulose therapy. Although initially showing some improvement in mental status, with a temporary reduction in confusion, the patient now presents with increased somnolence and lethargy. A repeat arterial blood gas analysis reveals a significant metabolic alkalosis with a pH of 7.52, bicarbonate level of 30 mEq/L, and a decrease in serum potassium to 2.8 mEq/L, secondary to excessive gastrointestinal losses from diarrhea induced by lactulose. These findings necessitate a careful reassessment of the therapeutic approach, balancing the need to manage hepatic encephalopathy against the risk of precipitating further electrolyte imbalances and renal compromise.

Given this complex clinical picture, the healthcare team is faced with the challenge of recalibrating the patient's management plan. The decision is made to adjust the lactulose dosage to mitigate the risk of electrolyte disturbances while considering alternative strategies to address hepatic encephalopathy, such as the introduction of rifaximin. Additionally, the team prepares for potential renal replacement therapy should the patient's renal function continue to decline. This evolving scenario demands vigilant monitoring and flexibility in clinical decision-making to navigate the intricate interplay of liver and renal failure, aiming to stabilize the patient and prevent further complications.

Section 3

As the healthcare team continues to closely monitor the patient, new diagnostic results provide further insight into the evolving clinical picture. A repeat abdominal ultrasound reveals evidence of ascites with increased peritoneal fluid, suggestive of further decompensation of liver function. This finding correlates with a worsening liver profile, as shown by a total bilirubin level that has climbed to 5.8 mg/dL and an INR of 2.1, indicating a significant impairment in the liver's synthetic capacity. Additionally, the patient's serum ammonia levels remain elevated at 130 µmol/L, underscoring the persistent challenge of managing hepatic encephalopathy in the context of deteriorating liver function.

Amidst these developments, the patient's vital signs reveal signs of hemodynamic instability, with a blood pressure of 88/56 mmHg and a heart rate of 112 beats per minute, suggesting potential circulatory compromise either due to the progression of hepatorenal syndrome or secondary to the increasing intra-abdominal pressure from ascites. Respiratory rate is noted at 24 breaths per minute with an oxygen saturation of 92% on room air, raising concerns about potential respiratory compromise. These changes prompt the healthcare team to evaluate the need for more aggressive fluid management and possible escalation of care, including consideration for vasopressor support.

The situation is further complicated by the emergence of a new complication: the patient begins to exhibit signs of gastrointestinal bleeding, evidenced by melena and a drop in hemoglobin from 10.5 g/dL to 8.2 g/dL over a period of 12 hours. This alarming development necessitates urgent endoscopic evaluation to determine the source of bleeding, while simultaneously managing the patient's coagulopathy and considering transfusion support. The unfolding scenario requires meticulous coordination and advanced clinical reasoning to prioritize interventions that address the multifaceted challenges of liver failure, renal impairment, and hemodynamic instability, all while striving to prevent further deterioration in this critically ill patient.

Section 4

As the healthcare team responds to the emergent situation, a focused initial assessment is conducted to ascertain the extent of the patient's current condition. The patient's neurological status is evaluated, revealing progressive confusion and disorientation, consistent with worsening hepatic encephalopathy. The Glasgow Coma Scale score has decreased to 11, indicating a decline in cognitive function that necessitates immediate intervention to prevent further neurological compromise. In conjunction with these findings, the patient's respiratory status is reassessed, and auscultation of the lungs demonstrates decreased breath sounds at the bases, suggestive of pleural effusion secondary to the worsening ascites. The patient's oxygen saturation has further decreased to 88% despite supplemental oxygen, necessitating a reevaluation of respiratory support strategies.

Given the patient's hemodynamic instability and the presence of gastrointestinal bleeding, the clinical team prioritizes volume resuscitation while preparing for an urgent endoscopic evaluation. Intravenous fluids are administered cautiously, considering the risk of exacerbating ascites and pulmonary edema. Blood products, including packed red blood cells and fresh frozen plasma, are ordered to address the significant drop in hemoglobin and the coagulopathy reflected by the elevated INR. Despite initial resuscitation efforts, the patient's blood pressure remains critically low at 86/54 mmHg, prompting the initiation of vasopressor support with norepinephrine to stabilize the cardiovascular status.

During the attempt to stabilize the patient, a new complication arises: the patient develops acute kidney injury, evidenced by a rise in serum creatinine from 1.2 mg/dL to 2.4 mg/dL over 24 hours, indicating the progression of hepatorenal syndrome. The decreased urine output to less than 0.5 mL/kg/hr further emphasizes the gravity of renal impairment. The healthcare team is now faced with the challenging task of balancing the need for aggressive fluid resuscitation with the potential for worsening renal function, all while coordinating the timing of the endoscopic procedure to control the gastrointestinal bleeding. This complex clinical scenario demands a high level of critical thinking and coordination among the multidisciplinary team to prioritize interventions and prevent further deterioration of the patient's condition.

Section 5

As the healthcare team continues to manage the complex case, new diagnostic results return, offering insights into the patient's rapidly evolving condition. A recent abdominal ultrasound reveals a significant increase in ascitic fluid volume, placing additional pressure on the diaphragm and contributing to the patient's respiratory compromise. The ultrasound also uncovers evidence of portal vein thrombosis, which complicates the hemodynamic management by further impairing hepatic blood flow and exacerbating the portal hypertension. This finding necessitates the initiation of anticoagulation therapy, which must be carefully balanced against the risk of worsening the gastrointestinal bleed.

Simultaneously, laboratory results indicate a further derangement in the patient's liver function tests, with a dramatic rise in bilirubin levels to 15 mg/dL, and worsening transaminase levels, suggesting acute liver decompensation. The patient's ammonia levels have also increased significantly, correlating with the deterioration in mental status as the hepatic encephalopathy advances. The elevated INR remains a concern, reaching 3.5, which heightens the risk of bleeding and complicates the decision-making process for anticoagulation and corrective interventions.

Despite the implementation of norepinephrine for vasopressor support, the patient's hemodynamic status remains tenuous, with blood pressure fluctuating between 85/50 mmHg and 90/55 mmHg. The team must now consider escalating the level of care, which may include transferring the patient to a higher acuity setting for possible liver transplant evaluation. This decision requires weighing the risks and benefits of continuing aggressive management in a rapidly deteriorating clinical picture, all while coordinating advanced life support measures to prevent further systemic complications. The immediate focus remains on stabilizing the patient's condition to allow for any potential future interventions, highlighting the critical need for precise clinical judgment and multidisciplinary collaboration.